Allopurinol induced erythroderma

Allopurinol, a widely prescribed urate lowering agent is responsible for various adverse drug reactions, including erythroderma. A 45-year-old male patient was admitted with the complaints of fever, redness and scaling all over the body after 3-4 weeks of allopurinol treatment for asymptomatic hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Geeta, Govil, Dinesh Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847258/
https://www.ncbi.nlm.nih.gov/pubmed/24347776
http://dx.doi.org/10.4103/0253-7613.121381
_version_ 1782293575804911616
author Sharma, Geeta
Govil, Dinesh Chandra
author_facet Sharma, Geeta
Govil, Dinesh Chandra
author_sort Sharma, Geeta
collection PubMed
description Allopurinol, a widely prescribed urate lowering agent is responsible for various adverse drug reactions, including erythroderma. A 45-year-old male patient was admitted with the complaints of fever, redness and scaling all over the body after 3-4 weeks of allopurinol treatment for asymptomatic hyperuricemia. Elevated liver enzymes were detected in his blood analysis. Skin biopsy was consistent with drug induced erythroderma. Allopurinol was stopped and steroids were started. Patient improved over a period of 2 weeks.
format Online
Article
Text
id pubmed-3847258
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38472582013-12-16 Allopurinol induced erythroderma Sharma, Geeta Govil, Dinesh Chandra Indian J Pharmacol Drug Watch Allopurinol, a widely prescribed urate lowering agent is responsible for various adverse drug reactions, including erythroderma. A 45-year-old male patient was admitted with the complaints of fever, redness and scaling all over the body after 3-4 weeks of allopurinol treatment for asymptomatic hyperuricemia. Elevated liver enzymes were detected in his blood analysis. Skin biopsy was consistent with drug induced erythroderma. Allopurinol was stopped and steroids were started. Patient improved over a period of 2 weeks. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3847258/ /pubmed/24347776 http://dx.doi.org/10.4103/0253-7613.121381 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Sharma, Geeta
Govil, Dinesh Chandra
Allopurinol induced erythroderma
title Allopurinol induced erythroderma
title_full Allopurinol induced erythroderma
title_fullStr Allopurinol induced erythroderma
title_full_unstemmed Allopurinol induced erythroderma
title_short Allopurinol induced erythroderma
title_sort allopurinol induced erythroderma
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847258/
https://www.ncbi.nlm.nih.gov/pubmed/24347776
http://dx.doi.org/10.4103/0253-7613.121381
work_keys_str_mv AT sharmageeta allopurinolinducederythroderma
AT govildineshchandra allopurinolinducederythroderma

Ejemplares similares